Form 4: Boston Scientific Executive Exercises Stock Options and Sells Shares
SEC Form 4 Filing
Eric Francis Yves Thepaut, an EVP at Boston Scientific, exercised stock options and sold shares on May 10, 2024.
Summary
- On May 10, 2024, Eric Francis Yves Thepaut, an Executive Vice President at Boston Scientific, exercised stock options to acquire 12,931 shares of common stock at a price of $16.31 per share.
- Thepaut then sold these 12,931 shares at a weighted average price of $74.141 per share, with individual sales ranging from $74.13 to $74.165.
- Following these transactions, Thepaut directly owns 31,421.99 shares of Boston Scientific common stock.
- Thepaut also continues to hold stock options.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions, with no inherent positive or negative sentiment. It reflects routine executive compensation activity.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.
Comparison to Industry Standards
- Executive stock option exercises and sales are common across publicly traded companies, particularly in the healthcare and medical device sectors.
- Comparing Thepaut's transactions to those of executives at similar companies like Medtronic (MDT) or Abbott Laboratories (ABT) would provide context on the scale and frequency of such activities.
- Benchmarking the option exercise price and sale price against industry averages for executive compensation packages can offer further insights.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the effect is likely negligible given the overall size of the company.
- Thepaut's actions could be viewed by some as a positive signal, indicating confidence in the company's future, or as a negative signal, suggesting a desire to realize gains.
Key Dates
| Date | Description |
|---|---|
| 02/23/2016 | First anniversary of the date of grant for the stock option, vesting in four equal annual installments. |
| 02/23/2025 | Expiration date of the stock option. |
| 05/10/2024 | Date of transaction: exercise of stock options and sale of shares. |
| 05/13/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.